Press coverage about PhotoMedex (NASDAQ:PHMD) has trended somewhat negative on Monday, Alpha One reports. The research group, a unit of Accern, identifies negative and positive press coverage by monitoring more than twenty million news and blog sources. Alpha One ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. PhotoMedex earned a news sentiment score of -0.02 on Alpha One’s scale. Alpha One also assigned media headlines about the medical equipment provider an impact score of 93 out of 100, meaning that recent press coverage is extremely likely to have an effect on the stock’s share price in the next several days.

PhotoMedex (NASDAQ:PHMD) traded down 1.496% during mid-day trading on Monday, hitting $1.251. 17,386 shares of the company were exchanged. The stock’s 50 day moving average is $1.65 and its 200-day moving average is $1.92. The company’s market cap is $5.29 million. PhotoMedex has a 12-month low of $0.90 and a 12-month high of $5.60.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at

PhotoMedex Company Profile

PhotoMedex, Inc is a global health products and services company providing integrated disease management and solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions, including acne and photo damage. The Company operates through three business segments: Consumer segment, Physician Recurring segment and Professional segment.

5 Day Chart for NASDAQ:PHMD

Receive News & Ratings for PhotoMedex Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PhotoMedex Inc and related companies with's FREE daily email newsletter.